Breaking News Instant updates and real-time market news.

ELGX

Endologix

$4.74

0.04 (0.85%)

16:04
08/09/18
08/09
16:04
08/09/18
16:04

Endologix cuts FY18 GAAP EPS view to ($1.12)-($1.04) from (95c)-(89c)

Consensus (58c). Cuts FY18 revenue view to $145M-$155M from $170M-$180M, consensus $175.6M.

  • 09

    Aug

  • 06

    Nov

ELGX Endologix
$4.74

0.04 (0.85%)

10/09/17
ADAM
10/09/17
NO CHANGE
Target $5
ADAM
Hold
Endologix investors should take profits, says Canaccord
Canaccord analyst Jason Mills believes the run in Endologix shares following the FDA approval of the NELLIX confirmatory study is "egregiously overdone" and as a result investors should take profits. Mills, who remains cautious about the company's ability to gain market share in a highly competitive and mature market, maintained his Hold rating and $5.00 price target on Endologix shares.
12/12/17
PIPR
12/12/17
INITIATION
Target $7
PIPR
Overweight
Endologix assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brian assumed coverage of Endologix with an Overweight rating and $7 price target. The analyst views the company as a "solid player" in the abdominal aortic aneurysms space despite some setbacks.
01/02/18
JPMS
01/02/18
DOWNGRADE
Target $5
JPMS
Underweight
Endologix downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Endologix to Underweight and cut his price target for the shares to $5 from $6. The outlook for the company continued to "deteriorate" over the course of 2017 as pipeline and regulatory challenges mounted, Weinstein tells investors in a research note. He sees an "uncertain path to profitability" and a "very long" road to recovery for Endologix.
03/20/18
PIPR
03/20/18
NO CHANGE
PIPR
Endologix ENCORE study a positive sign, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien was positive on Endologix's ENCORE study results for its Ovation product, and continues to believe "additional data reads and imminent approvals in the coming years should lift shares higher." O'Brien maintained an Overweight rating on shares, recommending investors with more risk tolerance or a longer time horizon accumulate shares at this point.

TODAY'S FREE FLY STORIES

03:45
09/26/18
09/26
03:45
09/26/18
03:45
General news
FX Action: The dollar could be in for a fall »

FX Action: The dollar…

03:35
09/26/18
09/26
03:35
09/26/18
03:35
General news
FX Action: USD-CAD has remained settled in the mid 1.2900s »

FX Action: USD-CAD has…

03:00
09/26/18
09/26
03:00
09/26/18
03:00
Conference/Events
Morgan Stanley India strategist to hold analyst/industry conference call »

Equity India Strategist…

02:40
09/26/18
09/26
02:40
09/26/18
02:40
General news
FX Update: Mostly narrow ranges have prevailed »

FX Update: Mostly narrow…

02:10
09/26/18
09/26
02:10
09/26/18
02:10
General news
FX Action: USD-JPY traded above 113.00 »

FX Action: USD-JPY traded…

01:40
09/26/18
09/26
01:40
09/26/18
01:40
General news
Asian Market Wrap: »

Asian Market Wrap:…

KKR

KKR

$28.12

-0.13 (-0.46%)

21:13
09/25/18
09/25
21:13
09/25/18
21:13
Hot Stocks
KKR forms management company to provide health care services in China »

KKR announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$70.38

0.43 (0.61%)

21:11
09/25/18
09/25
21:11
09/25/18
21:11
Hot Stocks
Agilent acquires ACEA Bioscience for $250M in cash »

Agilent Technologie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

EQM

EQT Midstream Partners

$52.64

-2.16 (-3.94%)

20:58
09/25/18
09/25
20:58
09/25/18
20:58
Recommendations
EQT Midstream Partners analyst commentary at MUFG »

EQT Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

20:42
09/25/18
09/25
20:42
09/25/18
20:42
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IGC

IGC, Inc

$2.32

-0.22 (-8.66%)

20:40
09/25/18
09/25
20:40
09/25/18
20:40
Hot Stocks
IGC to enter Hemp/CBD-infused energy drink space »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$57.10

-0.33 (-0.57%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Breaking Periodicals news story on Delta Air Lines »

Delta Air Lines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

20:32
09/25/18
09/25
20:32
09/25/18
20:32
Periodicals
Trump considering keeping Deputy AG Rosenstein, WSJ says »

Donald Trump has…

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCE

Arco Platform

$0.00

(0.00%)

20:31
09/25/18
09/25
20:31
09/25/18
20:31
Syndicate
Arco Platform 11.111M share IPO priced at $17.50 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KMX

CarMax

$75.87

-0.01 (-0.01%)

20:25
09/25/18
09/25
20:25
09/25/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

AINC

Ashford

$75.95

-11.75 (-13.40%)

20:23
09/25/18
09/25
20:23
09/25/18
20:23
Syndicate
Ashford 270K share Secondary priced at $74.50 »

UBS, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 26

    Sep

ANAB

AnaptysBio

$94.68

-7.25 (-7.11%)

20:21
09/25/18
09/25
20:21
09/25/18
20:21
Syndicate
AnaptysBio 2.2M share Secondary priced at $94.46 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SF

Stifel Financial

$53.96

-0.08 (-0.15%)

20:01
09/25/18
09/25
20:01
09/25/18
20:01
Hot Stocks
Stifel Financial and Everbright Sun Hung Kai establish strategic partnership »

Stifel Financial and Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

I

Intelsat

$27.08

4.365 (19.22%)

19:59
09/25/18
09/25
19:59
09/25/18
19:59
Hot Stocks
Intelsat and Azercosmos announce successful satellite launch »

Intelsat S.A. and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$30.88

0.66 (2.18%)

19:49
09/25/18
09/25
19:49
09/25/18
19:49
Hot Stocks
Breaking Hot Stocks news story on Skyline »

Centerbridge Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

, AIR

AAR Corp.

$46.03

1.04 (2.31%)

19:28
09/25/18
09/25
19:28
09/25/18
19:28
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$25.29

-0.24 (-0.94%)

AIR

AAR Corp.

$46.03

1.04 (2.31%)

VSTM

Verastem

$7.15

-1.74 (-19.57%)

CGIX

Cancer Genetics

$1.22

-0.01 (-0.81%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

NLSN

Nielsen

$27.21

0.055 (0.20%)

CYH

Community Health

$3.41

-0.08 (-2.29%)

AUPH

Aurinia Pharmaceuticals

$5.89

0.02 (0.34%)

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

ABBV

AbbVie

$93.78

0.34 (0.36%)

NKE

Nike

$84.79

0.52 (0.62%)

CTAS

Cintas

$212.99

1.81 (0.86%)

LULU

Lululemon

$158.42

1.04 (0.66%)

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 04

    Oct

  • 05

    Oct

  • 26

    Sep

CBS

CBS

$56.54

-0.07 (-0.12%)

19:19
09/25/18
09/25
19:19
09/25/18
19:19
Hot Stocks
CBS names Richard Parsons interim chairman »

Richard Parsons has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ZUMZ

Zumiez

$27.00

-0.55 (-2.00%)

19:09
09/25/18
09/25
19:09
09/25/18
19:09
Initiation
Zumiez initiated at DA Davidson »

Zumiez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$97.54

0.26 (0.27%)

, TJX

TJX

$110.33

0.605 (0.55%)

19:03
09/25/18
09/25
19:03
09/25/18
19:03
Initiation
Ross Stores, TJX initiated at DA Davidson »

Ross Stores initiated…

ROST

Ross Stores

$97.54

0.26 (0.27%)

TJX

TJX

$110.33

0.605 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MNOV

MediciNova

$11.68

-0.17 (-1.43%)

19:01
09/25/18
09/25
19:01
09/25/18
19:01
Hot Stocks
MediciNova announces 'positive' FDA feedback on Phase 3 plan for MN-166 »

MediciNova announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.